Identifying a Novel DPYD Polymorphism Associated with Severe Toxicity to 5‐FU Chemotherapy in a Saudi Patient
Case Reports in Genetics · 2019-01 · 2019 (1)
DOI: 10.1155/2019/5150725 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Genetics, online erschienen am 21.08.2019. Verfasst von Nedal Bukhari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, King Fahad Specialist Hospital in Dammam, Saudi Arabia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Dihydropyrimidine dehydrogenase (DPD) is the major enzyme in the catabolism of 5‐Fluorouracil (5‐FU) and its prodrug capecitabine. We report a 65‐year‐old female with rectal adenocarcinoma who experienced severe toxicities secondary to standard dose 5‐FU based chemotherapy. She was found to be heterozygous for rs371313778, c.2434G>A. This finding prompted restarting 5‐FU at 50% dose reduction with further titration in subsequent cycles. We herein report the first case of rs371313778, c.2434G>A (p.Val812lle) DPYD polymorphism leading to severe 5‐FU toxicities. The patient eventually completed a 6‐month course of adjuvant treatment with modification of 5‐FU dose.
Autor:innen und Institutionen
- Department of Medical Oncology, King Fahad Specialist Hospital in Dammam, Saudi Arabia.
- Department of Internal Medicine, King Fahad University Hospital, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
- Department of Internal Medicine, University of Jeddah, Jeddah, Saudi Arabia.
- Department of Internal Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
ORCID-Profile: Nedal Bukhari
Zitieren
APA
Bukhari, N., Azam, F., Alfawaz, M., & Zahrani, M. (2019). Identifying a Novel DPYD Polymorphism Associated with Severe Toxicity to 5‐FU Chemotherapy in a Saudi Patient. Case Reports in Genetics, 2019(1). https://doi.org/10.1155/2019/5150725
Vancouver
Bukhari N, Azam F, Alfawaz M, Zahrani M. Identifying a Novel DPYD Polymorphism Associated with Severe Toxicity to 5‐FU Chemotherapy in a Saudi Patient. Case Reports in Genetics. 2019;2019(1). doi:10.1155/2019/5150725
BibTeX
@article{Bukhari2019,
author = {Bukhari, Nedal and Azam, Faisal and Alfawaz, Mohammed and Zahrani, Mohammed},
title = {Identifying a Novel DPYD Polymorphism Associated with Severe Toxicity to 5‐FU Chemotherapy in a Saudi Patient},
journal = {Case Reports in Genetics},
year = {2019},
volume = {2019},
number = {1},
doi = {10.1155/2019/5150725}
}
EUVIMED